Home›Companies›Biotech & Pharma›Portal

Portal Biotechnologies, Inc.

Cell engineering instruments and kits for researchers and drug developers.

Updated Nov 10, 2026·Latest SEC filing May 29, 2026·Suggest an edit

About Portal

Portal is a private company based in Arlington, Massachusetts, incorporated in 2022 in Delaware. It has reported $20,694,997 raised in two offerings on Form D since December 2024. Its chief executive is Armon Sharei.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 15, 2026May 29, 2026$8,999,999fully sold12$749KEquityRule 506(b)Form D ↗
Dec 11, 2024Dec 26, 2024amended May 29, 2026$11,694,998of $11.9M target43$271KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$20,694,997

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Portal's Form D filed May 29, 2026.

Armon Sharei
Armon Sharei
Founder and CEO, director

Earlier filings also listed Alec Barlcay (chief technology officer and director, last listed May 2026).

Sources

  1. SECPortal Biotechnologies, Inc. Form D, filed Dec 26, 2024
  2. SECPortal Biotechnologies, Inc. filing history
  3. CompanyAbout Portal
  4. CompanyPortal news